{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:52:01Z","timestamp":1789451521837,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T00:00:00Z","timestamp":1263513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> It is likely that transmission of variant Creutzfeldt\u2010Jakob disease (vCJD) occurs by transfusion and that the candidate infectious agent (PrP<jats:sup>TSE<\/jats:sup>) is present in small concentrations in the blood of infected donors in the asymptomatic phase of the disease. A new blood screening assay has been developed to detect PrP<jats:sup>TSE<\/jats:sup> in citrated plasma samples.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> Three regional Blood Transfusion Establishments (ETS) in France (ETS Alsace, ETS Bourgogne Franche\u2010Comt\u00e9, and ETS Pyr\u00e9n\u00e9es\u2010M\u00e9diterran\u00e9e) will screen 60,000 plasma samples (20,000 in each ETS) over a time period of approximately 9 to 12 months.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Results provided in this report are those of the first testing site in Strasbourg, Alsace. The preliminary results have demonstrated an initial specificity of 97.60%. Upon repeat testing the specificity rate achieved 99.90% (20 repeat\u2010positive samples). Based on the known epidemiology of vCJD in France, it is likely that the repeat\u2010reactive samples are not true\u2010positives.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> The screening assay was studied in terms of specificity and practicality and was found to be suitable for use in routine testing of blood donations. However, throughput must be enhanced by automation of the assay, and traceability would be improved if automated systems were used to distribute and identify samples.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2009.02569.x","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T18:31:10Z","timestamp":1263580270000},"page":"989-995","source":"Crossref","is-referenced-by-count":9,"title":["Feasibility study of a screening assay that identifies the abnormal prion protein PrP<sup>TSE<\/sup> in plasma: initial results with 20,000 samples"],"prefix":"10.1111","volume":"50","author":[{"given":"Philippe","family":"Guntz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Schosseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joliette","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Pierre","family":"Cazenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,28]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16811-6"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69835-8"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00833.x"},{"key":"e_1_2_8_6_2","first-page":"2","article-title":"New case of transfusion\u2010associated variant\u2010CJD","volume":"16","author":"Health Protection Agency","year":"2006","journal-title":"CDR Wkly"},{"key":"e_1_2_8_7_2","volume-title":"4th case of variant CJD infection associated with blood transfusion (press release)","author":"Health Protection Agency","year":"2007"},{"key":"e_1_2_8_8_2","first-page":"pii=3117","article-title":"Fourth case of transfusion\u2010associated vCJD infection in the United Kingdom","volume":"12","author":"Editorial Team","year":"2007","journal-title":"Euro Surveill"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.02044.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2009.01161.x"},{"key":"e_1_2_8_11_2","unstructured":"NHS Tenders: Technology and Equipment.Contract notice 2009\/S 53\u2010076565 18 Mar2009. [cited 2009 Dec 24]. Available from: URL:http:\/\/www.nhstenders.net\/print\/php?sid=38339"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00411.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0041-1132.2003.00586.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15487-1"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16812-8"},{"key":"e_1_2_8_16_2","unstructured":"Spongiform Encephalopathy Advisory Committee (SEAC).Position statement on TSE infectivity in blood. 16 July2004. [cited 2009 Dec 24]. Available from: URL:http:\/\/www.seac.gov.uk\/statements\/statement0806.htm"},{"key":"e_1_2_8_17_2","unstructured":"Spongiform Encephalopathy Advisory Committee (SEAC).Position statement on evaluation criteria for ante mortem diagnostic tests for subclinical vCJD. November2006. [cited 2009 Dec 24]. Available from: URL:http:\/\/www.seac.gov.uk\/statements\/statement\u2010vcjd.pdf"},{"key":"e_1_2_8_18_2","unstructured":"WattsS.Fears raised over new vCJD wave. BBC News. 17 December2008. [cited 2009 Dec 24]. Available from: URL:http:\/\/news.bbc.co.uk\/go\/pr\/fr\/\u2010\/2\/hi\/health\/7788627.stm"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68930-7"},{"key":"e_1_2_8_20_2","volume-title":"vCJD abnormal prion protein found in a patient with haemophilia at post mortem (press release)","author":"Health Protection Agency","year":"2009"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1631-0691(02)01410-5"},{"key":"e_1_2_8_22_2","article-title":"Analyse du risque de transmission de la variante de la maladie de Creutzfeldt\u2010Jakob (vMCJ) par les produits de sant\u00e9 d'origine humaine","volume":"26","author":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9","year":"2009","journal-title":"Rep AFSSaPS"},{"key":"e_1_2_8_23_2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/clinchem\/32.5.801","article-title":"Differences between young and elderly subjects in seasonal and circadian variations of total plasma proteins and blood volume as reflected by hemoglobin, hematocrit, and erythrocyte counts","volume":"32","author":"Touitou Y","year":"1986","journal-title":"Clin Chem"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2009.02569.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2009.02569.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:37:59Z","timestamp":1697258279000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2009.02569.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,28]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1537-2995.2009.02569.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02569.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,28]]}}}